Home

Richard James Whitley

CIK 1441661 · last filed 2026-06-17

Richard James Whitley is a corporate insider who has filed 70 SEC Form 4 insider transactions across 3 companies since 2008. The most recent filing, for DWTX, was dated Jun 17, 2026. Across all open-market trades the lifetime net is −$8.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.4M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$4.44M

Companies

3

Total Filings

70

Lifetime Open-Market Net

-$8.48M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
DWTX Director — $1.55 — $0 3 2026-06-17
Dogwood Therapeutics, Inc. (VIRI) Delisted Director 28 $3.88 $108 $13.2K 8 2024-02-28
GILD Director 33,058 $134.32 $4.44M -$8.49M 59 2021-05-07

Recent Filings

70 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-17 DWTX Grant (A) — $0 EDGAR
2025-07-01 DWTX Grant (A) — $0 EDGAR
2025-06-23 DWTX Grant (A) — $0 EDGAR
2024-02-28 Dogwood Therapeutics, Inc. (VIRI) Delisted Grant (A) — $0 EDGAR
2023-06-20 Dogwood Therapeutics, Inc. (VIRI) Delisted Grant (A) — $0 EDGAR
2022-12-12 Dogwood Therapeutics, Inc. (VIRI) Delisted Sell (S) −1,800 -$466 EDGAR
2022-06-30 Dogwood Therapeutics, Inc. (VIRI) Delisted Grant (A) — $0 EDGAR
2022-05-19 Dogwood Therapeutics, Inc. (VIRI) Delisted Buy (P) +500 $2.3K EDGAR
2022-01-07 Dogwood Therapeutics, Inc. (VIRI) Delisted Buy (P) +1,800 $10.3K EDGAR
2021-12-23 Dogwood Therapeutics, Inc. (VIRI) Delisted Buy (P) +200 $1.1K EDGAR
Showing 1–10 of 70
Page 1 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.